Feedback / Questions
Jemperli (dostarlimab-gxly) - GSK
inupadenant (EOS-850) - iTeos
Keytruda (pembrolizumab) - Merck (MSD)
belrestotug (EOS-448) - iTeos, GSK
http://clinicaltrials.gov/ct2/show/NCT05060432
Jun 21, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next